1. Home
  2. MLAB vs EMBC Comparison

MLAB vs EMBC Comparison

Compare MLAB & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • EMBC
  • Stock Information
  • Founded
  • MLAB 1982
  • EMBC 1924
  • Country
  • MLAB United States
  • EMBC United States
  • Employees
  • MLAB N/A
  • EMBC N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • EMBC Medical/Dental Instruments
  • Sector
  • MLAB Industrials
  • EMBC Health Care
  • Exchange
  • MLAB Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • MLAB 680.0M
  • EMBC 716.2M
  • IPO Year
  • MLAB N/A
  • EMBC N/A
  • Fundamental
  • Price
  • MLAB $123.84
  • EMBC $11.97
  • Analyst Decision
  • MLAB Hold
  • EMBC Hold
  • Analyst Count
  • MLAB 2
  • EMBC 3
  • Target Price
  • MLAB $140.00
  • EMBC $17.67
  • AVG Volume (30 Days)
  • MLAB 38.2K
  • EMBC 450.3K
  • Earning Date
  • MLAB 05-30-2025
  • EMBC 05-09-2025
  • Dividend Yield
  • MLAB 0.52%
  • EMBC 5.01%
  • EPS Growth
  • MLAB N/A
  • EMBC N/A
  • EPS
  • MLAB N/A
  • EMBC 0.89
  • Revenue
  • MLAB $237,747,000.00
  • EMBC $1,079,500,000.00
  • Revenue This Year
  • MLAB $13.48
  • EMBC N/A
  • Revenue Next Year
  • MLAB $4.74
  • EMBC $0.99
  • P/E Ratio
  • MLAB N/A
  • EMBC $13.38
  • Revenue Growth
  • MLAB 11.68
  • EMBC N/A
  • 52 Week Low
  • MLAB $83.68
  • EMBC $10.12
  • 52 Week High
  • MLAB $155.12
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 58.56
  • EMBC 46.46
  • Support Level
  • MLAB $116.81
  • EMBC $12.08
  • Resistance Level
  • MLAB $128.55
  • EMBC $13.45
  • Average True Range (ATR)
  • MLAB 4.62
  • EMBC 0.59
  • MACD
  • MLAB 1.56
  • EMBC 0.13
  • Stochastic Oscillator
  • MLAB 76.09
  • EMBC 40.75

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: